Therefore, we would expect to detect a majority of chemokines (e.g. CXCL10, CXCL11) and cytokines (e.g. IL-17, IL-23) being differentially expressed across the different publications when comparing vitiligo patients to healthy controls or active vs stable vitiligo patients. The gene discussed is IL17A; the disease is vitiligo.